Antibodies

17 Jul 2017 New Evidence of Sutro ADC's Potency in Human Tumor Xenografts
17 Jul 2017 China's First Fully Human, Full-length Anti-PD-L1 Monoclonal Antibody Receives Approval to Initiate Clinical Trials by the China Food and Drug Administration
17 Jul 2017 Apexigen, Inc. Announces First Patient Dosed in Phase 1b/2 Clinical Trial of APX005M in Combination with Opdivo (nivolumab) in Advanced Solid Tumors
17 Jul 2017 Amgen And UCB Provide Update On Regulatory Status Of EVENITY™ (romosozumab) In The US
14 Jul 2017 Janssen announces u.s. FDA approval of Tremfya™ (guselkumab) for the treatment of moderate to severe plaque psoriasis
14 Jul 2017 Aduro Announces Milestone Achieved Relating to Collaboration with Merck for Development of Anti-CD27 Antibody for the Treatment of Cancer
14 Jul 2017 FDA Oncologic Drugs Advisory Committee Unanimously Recommends Approval of Mylan and Biocon's Proposed Biosimilar Trastuzumab
12 Jul 2017 FDA Advisory Committee Votes in Favor of Pfizer’s MYLOTARG (gemtuzumab ozogamicin) for Acute Myeloid Leukemia
12 Jul 2017 FDA Grants Full Approval for BLINCYTO® (blinatumomab) to Treat Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia in Adults and Children
11 Jul 2017 Valerion Initiates VAL-1221 Dosing in Patients with Pompe Disease
10 Jul 2017 PDS Biotechnology Corp. Announces Clinical Collaboration with Merck to Evaluate Combination of Versamune® PDS0101 and KEYTRUDA® (pembrolizumab) for Metastatic Head and Neck Cancer
10 Jul 2017 Exelixis and Bristol-Myers Squibb Initiate Phase 3 Trial of Opdivo® in Combination with CABOMETYX™ or Opdivo and Yervoy® in Combination with CABOMETYX, Versus Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
10 Jul 2017 Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
10 Jul 2017 FDA Grants Priority Review for Lilly's Abemaciclib for the Treatment of Advanced Breast Cancer
06 Jul 2017 Bristol-Myers Squibb’s ORENCIA (abatacept) Receives FDA Approval for Treatment of Active Psoriatic Arthritis (PsA) in Adults
06 Jul 2017 Merck Provides Further Update on Three Multiple Myeloma Studies Evaluating KEYTRUDA® (pembrolizumab) in Combination with Pomalidomide or Lenalidomide
06 Jul 2017 Novartis receives approval in the EU for Cosentyx label update, includes long term superiority data versus Stelara in psoriasis
06 Jul 2017 Immunocore Announces Third Oncology Target Selected in Discovery Collaboration with GlaxoSmithKline
05 Jul 2017 Phase 3 Study Evaluating the Safety and Efficacy of Adjuvant Opdivo in Resected High-Risk Melanoma Patients Meets Primary Endpoint
05 Jul 2017 Daiichi Sankyo Announces Discontinuation of Etanercept Biosimilar (CHS-0214) Development in Japan
02 Jul 2017 FDA Grants Priority Review to HIV Monoclonal Antibody and Long-Acting Investigational Antiretroviral Ibalizumab
30 Jun 2017 BESPONSA® Approved in the EU for Adult Patients with Relapsed or Refractory B-cell Precursor Acute Lymphoblastic Leukemia
30 Jun 2017 CytomX Achieves Development Milestone in Strategic Oncology Collaboration with AbbVie for CD71-Targeting Probody Drug Conjugate
30 Jun 2017 FDA Approves Vectibix® (Panitumumab) For Use In Wild-Type RAS Metastatic Colorectal Cancer
30 Jun 2017 Celltrion and Teva Announce U.S. FDA Acceptance of Biologics License Application for Proposed Biosimilar to Rituxan® (rituximab)

La Merie Biologics

FREE Weekly News Bulletin

2016 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Top